Sort
11,323 grants matching “glioblastoma”
Rare Central Nervous System Cancers Initiative
$347,879Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Pten regulation of growth and neoplasia in the brain
$347,879Suzanne J Baker · St. Jude Children'S Research Hospital · R01 · FY2006 · NS
Identifying New Glioma-Associated Tumor Suppressors Oncogenes
$347,879Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
STAT3 Regulation of Glioblastoma Pathogenesis
$347,874Azad Bonni · Harvard Medical School · R01 · FY2009 · NS
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813Hai Yan · Duke University · R01 · FY2018 · NS
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
$347,813John H Sampson · Duke University · R01 · FY2017 · NS
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
$347,813John H Sampson · Duke University · R01 · FY2020 · NS
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813Hai Yan · Duke University · R01 · FY2017 · NS
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
$347,813John H Sampson · Duke University · R01 · FY2021 · NS
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
$347,813Aaron J Johnson · Mayo Clinic Rochester · R01 · FY2019 · NS
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813David M. Ashley · Duke University · R01 · FY2019 · NS
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
$347,813Aaron J Johnson · Mayo Clinic Rochester · R01 · FY2018 · NS
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
$347,813Aaron J Johnson · Mayo Clinic Rochester · R01 · FY2019 · NS
Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
$347,813John H Sampson · Duke University · R01 · FY2016 · NS
Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations
$347,813Hai Yan · Duke University · R01 · FY2016 · NS
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
$347,813Aaron J Johnson · Mayo Clinic Rochester · R01 · FY2017 · NS
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
$347,813John H Sampson · Duke University · R01 · FY2018 · NS
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
$347,813John H Sampson · Duke University · R01 · FY2019 · NS
CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
$347,813John H Sampson · Duke University · R01 · FY2017 · NS
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma
$347,798Alexander H. Stegh · Northwestern University At Chicago · P50 · FY2020 · CA
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
$347,770Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Meso-plex miRNA and protein profiling for cancer diagnostics using chip-integrate
$347,739Ryan C Bailey · University Of Illinois At Urbana-Champaign · R33 · FY2013 · CA
Molecular Imaging of Cardiac Stem Cell Therapy
$347,711Joseph C Wu · Stanford University · R01 · FY2011 · EB
Nano-therapeutics Reprogramming of Immunosuppressive Myeloid Cells Potentiate Radiotherapy for Glioblastoma
$347,701Peng Zhang · Northwestern University At Chicago · R37 · FY2024 · CA
Development of B-cell-based vaccine for Glioblastoma
$347,701Catalina Lee Chang · Northwestern University At Chicago · R37 · FY2024 · CA